$4.84▴ 9.01%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
$5.14MTTM operating cash
Pre-profit
It generates operating cash even though it has no reported profit yet.
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
-6.1%year over year
Weak
Revenue is contracting year over year.
Leverage
Highdebt to assets
Weak
High leverage relative to its assets.
More coming: dilution / share-count creep.
✦ The read
Lifecore Biomedical, Inc. is pre-profit. It generates operating cash even though it has no reported profit yet. Revenue is contracting year over year. High leverage relative to its assets.
Key numbers
Valuation
EPS (TTM)$-1.18
TTM (trailing 12 months, through fiscal Q1 FY2026)
Profitability
Net margin-29.4%
TTM (trailing 12 months, through fiscal Q1 FY2026)
Size
Revenue (TTM)$127.36M
TTM (trailing 12 months, through fiscal Q1 FY2026)
Signals and key numbers are from the fiscal Q1 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.